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Abstract: Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) among animals
and humans are a public health threat. This study analyzed the occurrence of ESBL-E in a high-risk
environment in a companion animal clinic and two animal patients’ households. In an intensive
care unit (ICU), rectal swabs from 74 dogs and cats, 74 hand swabs from staff and 298 swabs from
surfaces were analyzed for ESBL-E. Seventeen hospitalized patients (23%) and ten (3%) surfaces
in the ICU tested ESBL-E positive. Transmission chains for Klebsiella pneumoniae ST307 blaCTX-M-15
and Escherichia coli ST38 blaCTX-M-14, ST88 blaCTX-M-14 and ST224 blaCTX-M-1 were observed over
extended periods of time (14 to 30 days) with similar strains isolated from patients and the clinical
environment. After discharge, two colonized dogs (dogs 7 and 12) and their household contacts were
resampled. Dog 7 tested repeatedly positive for 77 days, dog 12 tested negative; six (24%) surfaces
in the household of the persistently colonized dog tested ESBL-E positive. The owner of dog 7 and
one of the owners of dog 12 were colonized. Based on whole genome sequencing, isolates from the
owners, their dogs and other ICU patients belonged to the same clusters, highlighting the public
health importance of ESBL-E in companion animal clinics.
Keywords: antimicrobial resistance; multidrug resistance; canine; feline; ESBL; home; hospital;
high-risk clone Klebsiella pneumoniae ST307
1. Introduction
Antimicrobial resistance in companion animals is of public health importance because
of the close contact between pets and their owners, which can facilitate the transmission of
resistant bacteria [1–9]. The trend towards intensive medical care of dogs and cats fosters
hospitalization and nosocomial infections [10–13] and has led to a growing number of
geriatric and immunosuppressed animal patients that are highly susceptible to infections,
including those with antimicrobial resistant microorganisms (ARM). Antimicrobial use,
which is discussed as one of the main drivers of resistance development, is common in
companion animal medicine, including the use of highest priority critically important
antimicrobials and even antibiotics of last resort, such as carbapenems, are administered in
some instances [14–24].
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The spread of ARM, such as extended-spectrum beta-lactamase-producing Enter-
obacteriaceae (ESBL-E), challenges human and veterinary healthcare settings worldwide
and poses a public health threat [25]. In addition to their plasmid-mediated resistance
to penicillins and cephalosporins, ESBL-E are often resistant to antibiotics such as fluoro-
quinolones, aminoglycosides, and sulfamethoxazole/trimethoprim [26]. Previous hospital-
ization, a raw food diet, elderly age, urinary or intra-abdominal infections, hepatic cirrhosis,
residence in overcrowded household districts and antimicrobial therapy are known risk
factors for ESBL-E colonization of dogs and cats [27–29]. In a recently published study,
21.4% of dogs and cats carried ESBL-E on admission to veterinary hospitals, whereas 53.7%
were colonized after 72 h of hospitalization [27]. This points towards an important role
of companion animal clinics in the transmission of ESBL-E [1,10–13,30]. However, the
transmission chains for ESBL-E within veterinary hospitals, especially in high-risk settings
such as intensive care units (ICUs), has not yet been resolved. Additionally, the impact of
colonized patients for ESBL-E dissemination in the households after discharge is unclear.
The close contact of companion animals in the household to their owners is thought to
be a risk factor for ARM transmission to owners. In households in which humans carry ESBL-
E, identical strains were detected in dogs from the same households [28,31]. Furthermore,
a study from human medicine documented that transmission rates of ESBL-E between
humans in household settings outnumbered transmission rates within the hospital, and
transmission rates of 23% and 25% for ESBL-producing Escherichia coli (E. coli) and Klebsiella
pneumoniae (K. pneumoniae), respectively, were documented within the households [32].
This indicates that household transmission between humans can play a substantial role
in the spread of ESBLE-E, but data regarding transmission between companion animals
and humans in households is limited. Furthermore, the contamination of the household
environment with ESBL-E by colonized pets has not yet been investigated.
The aims of this study thus were to analyze transmission chains of ESBL-E over a
45-day period in an intensive care unit, a high-risk environment in a companion animal
clinic, and to investigate ESBL-E dissemination by colonized patients to household contacts
and the environment in two households after discharge.
2. Results
2.1. ESBL-E in the Intensive Care Unit
A total of 91 rectal swab specimens from 49 dogs and 25 cats hospitalized in the
ICU, and 298 specimens from 25 predefined high–touch surfaces and from 74 hands from
healthcare workers in the ICU were collected at regular intervals on 12 sampling days over
a 45-day period. ESBL-E (E. coli and K. pneumoniae) were isolated from 12 (24%) dogs and
5 (20%) cats (Figure 1, Table S1) and from 3% of the high-touch surfaces (range: 0–28% per
sampling day; positive specimens: dog cage, area of drug preparation, small cabinet, blood
pressure monitor scale (floor), water tap, fridge with medication, scissors). None of the
hand swabs tested positive for ESBL-E.
ESBL-E genes detected in the clinic included blaCTX-M-1, blaCTX-M-14, blaCTX-M-15,
blaCTX-M-65, and blaCTX-M-216; blaCTX-M-15 was most common and detected in 8 of 10 (80%)
environment- and 10 of 23 (43%) patient-derived ESBL-E positive specimens. Additionally,
broad spectrum beta-lactamase genes blaSHV-1 and blaTEM-1 were detected amongst these
isolates (Table S1). Among the E. coli isolates, nine different sequence types were identi-
fied (Figure 1, Table S1). Among the K. pneumoniae isolates, ST15 and ST307 were found.
The phylogenetic relationship for all human-animal-environmental strains is shown in
Figures 2 and 3. K. pneumoniae ST307 blaCTX-M-15 predominated in the ICU, particularly on
day 22 where ESBL-E contamination of the ICU was most extensive (Figure 1, Table S1).
On this day, 7 (28%) environmental specimens tested positive for ESBL-E and six of these
isolates belonged to K. pneumoniae ST307 blaCTX-M-15.
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Transmission chains for several closely related ESBL-E isolates were detected within
the ICU over extended periods of time. K. pneumoniae ST307 blaCTX-M-15 was isolated for the
first time from dog 4 on day 15 and thereafter from different hospitalized patients (dogs 6
and 8; cats 1, 4 and 5; days 22–29) and environmental surfaces (days 22 and 45, Figure 1),
which indicates an ongoing transmission chain for this strain. Some of these isolates (dog 4,
day 15; cat 5, day 29; environmental specimens, days 22 and 45) were characterized by
whole genome sequencing (WGS) and core genome multi-locus sequence typing (cgMLST)
analysis which revealed that all selected isolates belonged to the same cluster.
Figure 1. Timeline of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) isolated from dogs, cats
and the clinical environment. D, dog; C, cat; d, sampling day; s, dog cage; j, area of drug preparation; i, small cabinet; t,
blood pressure monitor; w, scale (floor); f, water tap; l, fridge with medication; y, scissors; SK, subculture. Each horizontal
line refers to a specimen obtained from the same animal or environmental surface over time. The brackets at the left side of
the strain ID indicate subcultures of the same specimen. Negative test results are only shown for animals or environmental
surfaces that had tested positive for ESBL-E at a certain point in time.
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Additionally, three specific E. coli strains (ST88 blaCTX-M-14, ST224 blaCTX-M-1, ST38
blaCTX-M-14) were isolated on various sampling occasions in the ICU. E. coli ST88 blaCTX-M-14
was detected in dog 1 (days 3 and 8) and dog 2 (day 3) and was thereafter isolated from
dog 5 on day 17. E. coli ST224 blaCTX-M-1 first occurred in dog 7, cat 3 and the environment
on day 22, and was detected again 21 days later (day 43) in dog 11 and in the clinical
environment. Lastly, E. coli ST58 blaCTX-M-14 was isolated on a first occasion from in dog 9
on day 29 and again from dog 12 on day 45.
t1 SK1, dog household 1; H1f1, dog’s sleeping basket (living room); H1c1, water bowl; H1O1 t1 SK2, owner household 1; 
kitchen sponge; H1g1, dog’s blanket on terrace; D48, dog 7; H1O1 t2, 
owner household 1; H1h1, dog’s sleeping basket (bedroom); i11, small cabinet; H1CD1 t3, dog household 1; C17, cat 3; 
Figure 2. Multi-locus sequence typing-distance based phylogenetic tree for extended-spectrum beta-lactamase-producing
Escherichia coli isolates. D, dog; C, cat; CD, colonized dog; O, owner; lower case letter, environment; H1, household 1; H2,
household 2; D68, dog 10; D5, dog 1; H1O1 t1 SK1, owner household 1; H1O1 t4, owner household 1; H1CD1 t1 SK2 dog
household 1; D9, dog 1; D40, dog 5; D10, dog 2; D18, dog 1; C16 SK1, cat 2; D17, dog 2; H1CD1 t2, dog household 1; H1CD1
t1 SK1, dog household 1; H1f1, dog’s sleeping basket (living room); H1c1, water bowl; H1O1 t1 SK2, owner household 1; s7,
dog cage; D69 SK2, dog 11; H1m1, carpet; h1y1, kitchen sponge; H1g1, dog’s blanket on terrace; D48, dog 7; H1O1 t2, owner
household 1; H1h1, dog’s sleeping basket (bedroom); i11, s all cabinet; H1CD1 t3, dog household 1; C17, cat 3; H1CD1 t4
SK2, dog household 1; D26, dog 3; C16 SK2, cat 2; H2O2 t2, owner household 2; H2O2 t1, owner household 2; D58 SK2, dog
9; D72, dog 12; *, whole genome sequencing conducted.
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–
tively, between days 27 and 77 after the dog’
Figure 3. Multi-locus sequence typing-distance based phylogenetic tree for extended-spectrum beta-lactamase-producing
Klebsiella pneumoniae isolates. D, dog; C, cat; O, owner; lower case letter, environment; D55, dog 6; D54, dog 8; D46, dog 6;
C23, cat 5; D32, dog 4; f, water tap; i, small cabinet; j, area of drug preparation; l, fridge with medication; t, blood pressure
monitor; w, scale (floor); y, scissors; C15, cat 1; C21, cat 4; D69 SK3, dog 11; *, whole genome sequencing conducted.
2.2. ESBL-E in the Households
Two colonized dogs (dog 7, household 1; dog 12, household 2) were resampled at home
after discharge from the clinic, together with the household contacts and the household
environment (Figure 4). Household 1 contained dog 7 and the owner. Dog 7 and the owner
were found to be persistently and intermittently colonized with ESBL-E, respectively,
between days 27 and 77 after the dog’s discharge from the clinic, and both tested negative
on day 133. E. coli ST224 blaCTX-M-1 and ST5869 blaCTX-M-56 were detected in the dog, and E.
coli ST224 blaCTX-M-1 and ST10 blaCTX-M-15 in the owner. E. coli ST224 blaCTX-M-1 had already
been isolated from dog 7 during hospitalization (and from other ICU patients and the ICU
environment, see above) and was found in dog 7 on repeated samplings until day 77 after
discharge and in the owner until day 47 after the dog’s discharge (Figure 4). Isolates of E.
coli ST224 blaCTX-M-1 from dog 7 (day 47 after discharge), its owner (day 47 after discharge)
and clinic-derived specimens (cat 3, day 22; clinical environment, day 22) were subject to
WGS and cgMLST analysis and confirmed to belong to the same cluster.
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H1, household 1; H2, household 2; H1c1, water bowl; H1f1, dog’s sleeping basket (living room); H1g1, dog’s blan-
ket on terrace; H1h1, dog’s sleeping basket (bedroom); H1m1, carpet; 
–
Figure 4. Timeline of extended spectrum beta-lactamase producing Enterobacteriaceae (ESBL-E) isolated from the dogs, cats
and owners in household 1 and 2 and the household environment. CD, colonized dog; O, owner; d, days after discharge;
H1, household 1; H2, household 2; H1c1, water bowl; H1f1, dog’s sleeping basket (living room); H1g1, dog’s blanket on
terrace; H1h1, dog’s sleeping basket (bedroom); H1m1, carpet; H1y1, kitchen sponge; SK, subculture. Each horizontal
line refers to a specimen obtained from the same animal, owner or environmental surface over time (12, t2, t3, t4, t5). The
brackets at the right side of the strain ID indicate subcultures of the same specimen. Negative test results are only shown for
animals, environmental surfaces or owners that had tested positive for ESBL-E at a certain time point.
Environmental contamination with ESBL-E was detectable in 6 (24%) specimens in
household 1 (at day 47 after discharge) and all isolates belonged to E. coli ST224 blaCTX-M-1.
Areas in close contact with the dog, such as the carpet, the dog’s water bowl, the dog’s
sleeping basket in the living room, the dog’s blanket on the terrace and the dog’s sleeping
basket, but also the kitchen sponge, were contaminated, whereas areas primarily in contact
with the owner tested negative. The relatedness of the isolate deriving from the kitchen
sponge to the other Escherichia coli ST224 blaCTX-M-1 was confirmed through WGS and
cgMLST. Immediately after thorough cleaning with a commercially available household
cleaning product, none of the environmental specimens taken tested positive (day 57),
while the dog, but not the owner, remained consistently positive until day 77 (Figure 4).
Household 2 contained two people, two cats, the colonized dog 12 and another dog
(Figure 4). At the time of retesting (68 days after discharge), one of the two owners in
household 2 was colonized with E. coli ST38 blaCTX-M-14 while both dogs, the cats and
the other owner tested negative (Figure 4). The owner tested again positive for this
strain in the second sample collected 118 days after the dog’s discharge. E. coli ST38
blaCTX-M-14 had originally also been isolated from dog 12 of this household (on day 45
during hospitalization), and in another dog (dog 9, day 29) from the ICU 16 days before
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dog 12 was sampled. WGS and cgMLST analysis confirmed that the isolates of dogs 9
and 12 and of the owner of dog 12 (68 days after discharge) belonged to the same cluster.
Environmental contamination with ESBL-E was undetectable in this household (at day 68
after discharge) where only one owner, but not the dogs, was colonized with ESBL-E.
Hygiene standards were assessed in both households using a questionnaire
(Table S2). Overall, hygiene behavior did not clearly differ between the households. Own-
ers of both households indicated that they “regularly” used hand sanitizer and antibacterial
soap, none of the owners fed their dogs a raw food diet but both owners had contact to
the human health care system (the owner living in household 1 worked as a surgical
cosmetician, the owner in household 2 worked as a care professional in a nursing home).
Owners from both households indicated that kitchen towels were not changed daily and
that no separate chopping boards were used for meat and food of nonanimal origin.
2.3. Resistance Profiles of ESBL-E
Resistance profiles were determined for all ESBL-E isolates collected in this study.
The strains shared by the owner and the colonized dogs in households 1 and 2 showed
resistance to ampicillin, cephazolin, cefotaxime, cephepime, nalidixic acid, ciprofloxacin,
sulfamethoxazole-trimethoprim and streptomycin (Table S1). The E. coli strains in house-
hold 1 were additionally resistant to kanamycin, gentamicin and tetracycline, whereas the
E. coli strains in household 2 and from dogs 9 and 12 were also resistant to azithromycin.
3. Discussion
The present study documents transmission chains for several ESBL-producing E. coli
and K. pneumoniae strains in a high-risk setting of a companion animal clinic. Within the
limited time of observation (45 days), transmission chains for one K. pneumoniae and three
E. coli strains were documented, and the isolates included high-risk human pathogenic
clones such as K. pneumoniae ST307 which has been previously associated with carbapenem
and ESBL resistance [33–36]. This strain was repeatedly detected in ICU patients and the
clinical environmental over a period of 30 days, indicating an ongoing outbreak situation.
Our results underline that ICU settings in companion animal clinics could significantly
contribute to the spread of ESBL-E and high-risk human pathogenic clones.
Worryingly, the study also supports a direct transfer of ESBL-producing E. coli strains
from ICU patients to companion animal owners (or vice versa). A recent study found
that only 12% of the owners in households with a colonized dog were ESBL-E carriers.
Additionally, a match in the core genome between the owner and the dog specimen was
only found in 5% of the exposed households [28]. A previous study found that dog
ownership was not a risk factor for ESBL-E carriage [29], however, dogs are often colonized
with ESBL-E after hospitalization [27]. E. coli ST38 blaCTX-M 14 originally detected in two
ICU patients was isolated from the owner of one of these animal patients after the dog’s
discharge. Interestingly, the colonization of the owner was found at a time when the dog
tested negative for this strain, and colonization persisted for at least 50 days. WGS and
cgMLST confirmed the very close relationship of the isolates of the owner and the ICU
patients. Of note, the colonization of the owner was not associated with environmental
contamination with ESBL-E in this household. In the second household investigated in
this study, closely related E. coli ST224 blaCTX-M 1 isolates were detected in the owner and
its dog after discharge over extended periods of time, and considerable environmental
household contamination occurred with this strain (24% positive environmental surfaces).
The dog remained colonized with this E. coli strain for 77 days after discharge. In this
household, it was unclear whether the dog introduced this E. coli strain into the ICU and
caused a transmission chain to three other ICU patients, or whether colonization first
occurred during hospitalization and resulted in a transfer of the isolate into the household.
Again, WGS and cgMLST confirmed the very close relationship of the clinic- and owner-
derived isolates. The results underline that ESBL-E transmission chains can be frequent
in ICU settings in companion animal clinics and pose a risk for both, the animal owners
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and for other ICU patients. Interruption of these transmission chains by comprehensive
infection prevention and control (IPC) concepts including stringent adherence to hand
hygiene are thus of public health importance and should be urgently promoted. So far,
the implementation IPC concepts are, in contrast to human hospitals, not mandatory for
veterinary clinics in Switzerland.
Households have been previously described as a potential reservoir for ESBL-E [37,38].
Environmental contamination with ESBL-E in the household was extensive in household
1 with the persistently colonized dog but was undetectable in household 2 where only
the owner was colonized, although hygiene habits seemed to be comparable in the two
investigated households. Both owners indicated not using separate chopping boards for
meat and food of nonanimal origin and not changing kitchen towels daily, which could
both be an important source of transmission of ESBL-E [29,39]. Furthermore, ESBL-E
were primarily detected on surfaces in household 1 that were in close contact with the
persistently colonized dog. This could support the hypothesis that colonized companion
animals contribute more to household contamination with ESBL-E than colonized humans.
This is also supported by the fact that in household 1, E. coli ST224 blaCTX-M 1 was the only
detected strain in the dog during hospitalization and for 77 days after discharge, in contrast
to the owner, who was colonized with an additional strain, and only E. coli ST224 blaCTX-M 1
was detected in the household environment. Such long carriage periods could additionally
contribute to the risk of spreading of ESBL-E in the household environment [28]. Of note,
environmental contamination in household 1 for ESBL-E was much higher than at most
of the sampling days in the ICU in the investigated clinic (3%, range: 0–24%), and higher
than recently reported for environmental samples collected in seven companion animal
clinics and practices in Switzerland (0–2% of the environmental specimens were ESBL-E
positive) [40]. Although only two households were investigated in this study, our results
are alarming and highlight the need to develop evidence-based recommendations for the
handling of ESBL-E colonized animals in the household environment.
Overall, blaCTX-M-15, a highly prevalent ESBL gene in both humans and companion
animals, predominated in the clinical samples [41–44]. The previously described emergence
of blaCTX-M-1 and blaCTX-M-14 in dogs and cats in Switzerland was also evident in this
study [45]. ST307 has been previously described in a dog with a urinary tract infection from
Brazil [46]. Additionally, E. coli ST38 blaCTX-M-14, ST88 blaCTX-M-14 and ST224 blaCTX-M-1
reoccurred on different sampling occasions indicating additional minor outbreaks. ST224,
which was also isolated from the owner in this study, has been frequently reported in
companion animals [47–49]. ST88 is common among both humans and animals and
globally distributed [50]. Both ST88 and ST38 belong to global extraintestinal pathogenic E.
coli lineages and companion animals have been documented as a possible reservoir [51,52].
Furthermore, ST15, an epidemic and international human-related K. pneumoniae strain, was
isolated from one dog in this study. K. pneumoniae ST15 and E. coli ST10 and ST58 strains
have been previously isolated from clinical specimens of companion animal patients from
the same veterinary clinic in an unrelated study [45].
Data on environmental contamination by ESBL-E in veterinary facilities are scarce.
A recent study reported a prevalence of ESBL-E on high-touch surfaces ranging from
0–2% across seven Swiss veterinary clinics and practices [40] and areas with high patient
traffic and utensils were most contaminated with ARM [40]. In this study, environmental
contamination with ESBL-E in a high-risk setting was detected in 3% of the high-touch
surfaces, but contamination varied considerably between the sampling days: seven of
10 isolates were found on sampling day 22 and six of these seven specimens yielded K.
pneumoniae ST310 blaCTX-M-15.
ESBL-E was not isolated from any of the hand swabs in this study although hands are
regarded as one of the main vectors for ARM transmission. Considering the high number
of hand-animal contacts that take place during the daily work of healthcare workers, the
microbiological analyses of the swabs represent only a snapshot and cannot fully mirror
the transmission events in these settings. Previous studies have reported drug-resistant
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Enterobacteriaceae on the hands of veterinary staff [53] and nosocomial pathogens have
been isolated from the hands of healthcare workers [54].
The present study has some limitations. The ICU of only one veterinary clinic was
investigated in this study. An extrapolation of our results to ICU settings of other veterinary
clinics is thus not possible. Of note, the companion animal clinic included in this study
showed the lowest environmental ARM contamination and the highest IPC standards
among three large referral clinics in Switzerland in a recent study, suggesting that the
frequency of ESBL-E transmission chains observed in this study might not be overesti-
mated [40]. However, the present study also showed considerable variations in the ESBL-E
detection between sampling days. Furthermore, the present study investigated only two
households, and documentation of a colonized companion animal was only available in
one of the households. Furthermore, environmental sampling in the household differed
regarding the time after discharge. Future studies should thus further elucidate the ESBL-E
transmission chains between companion animals and owners in household settings.
4. Materials and Methods
4.1. Ethics
All methods were carried out in accordance with relevant guidelines and regulations.
In accordance with local legislation, ethical approval was sought from the Swiss Ethics
Committees on research involving humans (2019-00768). Informed consent was obtained
from all participants. Ethical approval for the collection of rectal swab specimens from the
dogs and cats was received from the local Veterinary Office (ZH028/19). All owners of the
dogs and cats gave informed consent.
4.2. Study Set-Up
4.2.1. Specimen Collection
Single cotton swabs were used for the collection of specimens. Rectal swab specimens
from all dogs and cats that were examined by the intensive care unit (ICU) of a veterinary
tertiary care facility between June 2019 and August 2019 were collected by the first author of
this study after informed owner consent. Sampling intervals were kept constant throughout
the study period (Figure 1). Swabs from a modified previously published list of high-touch
surfaces (Table S3) were collected in the ICU during the same time period [40]. During the
same time points, hand swabs of the dominant hand from veterinary staff (i.e., veterinarians,
nurses and students) working in the ICU were collected before and after animal patient
contact, regardless as to whether gloves were worn. If gloves were worn, the hand swab
was taken from the glove.
Two households were followed-up and were asked to send stool specimens of the
colonized animal patient and its household contacts (owner, dogs and cats living in the same
household) at different time points (Figure 4) and specimens from twenty-five surfaces with
high human and animal contact in the household (Table S4) were collected. Furthermore,
owners were asked to fill out a questionnaire on household hygiene (Table S2) [55–57].
There was no compensation for participating in the study.
4.2.2. Microbiological Analysis
Specimens from dogs, cats and owners of two colonized dogs, hand swabs and swabs
of high-touch surfaces from the clinic and the household environment were analyzed for
the presence of ESBL-E.
All swabs were immediately enriched in 10 mL peptone water (BioRad, Hercules, CA,
USA), followed by selective enrichment in Enterobacteriaceae enrichment broth (Oxoid,
Hampshire, UK). ESBL-E were screened by using the chromogenic medium Brilliance™
ESBL Agar (Oxoid, Hampshire, UK), according to the manufacturer’s instructions. Colonies
were picked from the selective media based on phenotype and species identification
was conducted by using matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF–MS, Bruker Daltronics, Bremen, Germany). Polymerase chain
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reaction (PCR) assays for the presence of genes encoding blaCTX-M groups, blaSHV and
blaTEM were conducted on Enterobacteriaceae isolates as previously described [45,58–60].
4.2.3. Antimicrobial Susceptibility Testing
Antimicrobial susceptibility testing was performed for Enterobacteriaceae in accor-
dance with the Clinical and Laboratory Standards Institute (CLSI) performance stan-
dards [61] using the disk-diffusion method on Mueller Hinton plates (Oxoid, Hamp-
shire, UK) and the antibiotics ampicillin (AM), amoxicillin with clavulanic acid (AMC),
azithromycin (AZM), cefazolin (CZ), cefepime (FEP), cefotaxime (CTX), chloramphenicol
(C), ciprofloxacin (CIP), fosfomycin (FOS), gentamicin (G), kanamycin (K), nalidixic acid
(NA), nitrofurantoin (F/M), streptomycin (S), sulfamethoxazole trimethoprim (SXT) and
tetracycline (TE) (Becton Dickinson, Allschwil, Switzerland). Results were interpreted
according to CLSI standards [61]. For azithromycin, an inhibition zone of ≤12 mm was
interpreted as resistant.
4.2.4. MLST
Sequence type determination of the identified Enterobacteriaceae isolates, i.e., E. coli
and K. pneumoniae, was carried out as published previously [62,63]. Sequence analysis was
conducted using RidomTM SeqSphere+ (Ridom© GmbH, Münster, Germany).
4.2.5. WGS
Whole genome sequencing was performed according to procedures previously de-
scribed on selected isolates from colonized dogs and cats, owners and clinical and house-
hold environment based on MLST results, genes encoding blaCTX-M groups, blaSHV and
blaTEM and antimicrobial susceptibility testing [64]. Briefly, the isolates were grown
overnight on sheep blood agar at 37 ◦C prior to genomic DNA isolation using the DNA
blood and tissue kit (Qiagen, Hombrechtikon, Switzerland). A Nextera DNA Flex Sample
Preparation Kit (Illumina, San Diego, CA, USA) was used to prepare the DNA, which
produces transposome-based libraries that were sequenced on an Illumina MiniSeq Se-
quencer (Illumina, San Diego, CA, USA). Reads were checked for quality using the software
package FastQC 0.11.7 (Babraham Bioinformatics, Cambridge, UK). Both Illumina-reads
files passed the standard quality checks of FastQC, with the exception of the module “Per
Base Sequence Content”, which returned a failure. Such failure is common for transposome-
based libraries and was therefore ignored and reads were assembled using the Spades 3.0
based software Shovill 1.0.4, using default settings. The assembly was filtered, retaining
contigs > 500 bp.
5. Conclusions
In conclusion, the present study documents transmission chains for the human
pathogenic K. pneumoniae ST307 strain and three ESBL-producing E. coli strains in an
ICU of a veterinary clinic over a 45-day observation period. The study strongly suggests
the transfer of ESBL-producing E. coli strains from the ICU setting to the patients’ house-
holds and pet owners, and vice versa, with extended periods of ESBL-E colonization in
the animals and owners. Contamination of the household environment in the case of a
persistently colonized dog was extensive and might outweigh contamination by colonized
humans. The study highlights the risk of veterinary clinics in the spread of ARM and the
need to further investigate transmission of ARM in companion animal households in order
to develop evidence-based recommendations on hygiene measures in these settings.
Supplementary Materials: The following are available online at https://www.mdpi.com/2079-638
2/10/2/171/s1, Table S1: Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E)
isolated from dogs, cats, clinical and household environment and owners of colonized pets, Table S2:
Questionnaire for the owners of colonized pets, Table S3: List of high-touch surfaces in the veterinary
clinic, Table S4: List of high-touch surfaces in the households of colonized pets.
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Baker, M.G.; et al. Carriage of extended-spectrum-beta-lactamase- and AmpC Beta-lactamase-producing Escherichia coli strains
from humans and pets in the same households. Appl. Environ. Microbiol. 2020, 86. [CrossRef]
38. Schages, L.; Lucassen, R.; Wichern, F.; Kalscheuer, R.; Bockmühl, D. The household re 1 sistome—frequency of β-lactamases, class
1 integron and 2 antibiotic resistant bacteria in the domestic environment and their reduction 3 during automated dishwash-
ing/laundering. Appl. Environ. Microbiol. 2020. [CrossRef] [PubMed]
39. Tschudin-Sutter, S.; Frei, R.; Stephan, R.; Hächler, H.; Nogarth, D.; Widmer, A.F. Extended-spectrum β-lactamase (ESBL)–
producing enterobacteriaceae: A threat from the kitchen. Infect. Control. Hosp. Epidemiol. 2014, 35, 581–584. [CrossRef]
[PubMed]
40. Schmidt, J.S.; Kuster, S.P.; Nigg, A.; Dazio, V.; Brilhante, M.; Rohrbach, H.; Bernasconi, O.J.; Büdel, T.; Campos-Madueno,
E.I.; Brawand, S.G.; et al. Poor infection prevention and control standards are associated with environmental contamination
with carbapenemase-producing Enterobacterales and other multidrug-resistant bacteria in Swiss companion animal clinics.
Antimicrob. Resist. Infect. Control 2020, 9, 1–13. [CrossRef] [PubMed]
41. Timofte, D.; Maciuca, I.E.; Williams, N.J.; Wattret, A.; Schmidt, V. Veterinary hospital dissemination of CTX-M-15 Extended-
spectrum beta-lactamase–producing Escherichia coli ST410 in the United Kingdom. Microb. Drug Resist. 2016, 22, 609–615.
[CrossRef] [PubMed]
42. Shaheen, B.W.; Nayak, R.; Foley, S.L.; Kweon, O.; Deck, J.; Park, M.; Rafii, F.; Boothe, D.M. Molecular characterization of resistance
to extended-spectrum cephalosporins in clinical Escherichia coli isolates from companion animals in the United States. Antimicrob.
Agents Chemother. 2011, 55, 5666–5675. [CrossRef] [PubMed]
43. Dahmen, S.; Haenni, M.; Châtre, P.; Madec, J.-Y. Characterization of blaCTX-M IncFII plasmids and clones of Escherichia coli from
pets in France. J. Antimicrob. Chemother. 2013, 68, 2797–2801. [CrossRef] [PubMed]
44. Valenza, G.; Schulze, M.; Friedrich, P.; Schneider-Brachert, W.; Holzmann, T.; Nickel, S.; Lehner-Reindl, V.; Höller, C. Screening of
ESBL-producing enterobacteriacae concomitant with low degree of transmission in intensive care and bone marrow transplant
units. Infect. Dis. 2017, 49, 405–409. [CrossRef] [PubMed]
45. Zogg, A.L.; Simmen, S.; Zurfluh, K.; Stephan, R.; Schmitt, S.N.; Nüesch-Inderbinen, M. High prevalence of extended-spectrum
β-lactamase producing enterobacteriaceae among clinical isolates from cats and dogs admitted to a veterinary hospital in
Switzerland. Front. Vet. Sci. 2018, 5, 62. [CrossRef] [PubMed]
46. Sartori, L.; Sellera, F.P.; Moura, Q.; Cardoso, B.; Cerdeira, L.; Lincopan, N. Multidrug-resistant CTX-M-15-positive Klebsiella
pneumoniae ST307 causing urinary tract infection in a dog in Brazil. J. Glob. Antimicrob. Resist. 2019, 19, 96–97. [CrossRef]
47. Marques, C.; Belas, A.; Franco, A.; Aboim, C.; Gama, L.T.; Pomba, C. Increase in antimicrobial resistance and emergence of major
international high-risk clonal lineages in dogs and cats with urinary tract infection: 16 year retrospective study. J. Antimicrob.
Chemother. 2018, 73, 377–384. [CrossRef]
48. Zhang, P.L.C.; Shen, X.; Chalmers, G.; Reid-Smith, R.J.; Slavic, D.; Dick, H.; Boerlin, P. Prevalence and mechanisms of extended-
spectrum cephalosporin resistance in clinical and fecal Enterobacteriaceae isolates from dogs in Ontario, Canada. Vet. Microbiol.
2018, 213, 82–88. [CrossRef]
49. Silva, M.M.; Sellera, F.P.; Fernandes, M.R.; Moura, Q.; Garino, F.; Azevedo, S.S.; Lincopan, N. Genomic features of a highly
virulent, ceftiofur-resistant, CTX-M-8-producing Escherichia coli ST224 causing fatal infection in a domestic cat. J. Glob. Antimicrob.
Resist. 2018, 15, 252–253. [CrossRef]
50. Day, M.J.; Schink, A.-K.; Chattaway, M.A.; Donascimento, V.; Threlfall, J.; Rodríguez, I.; van Essen-Zandbergen, A.; Dierikx, C.;
Kadlec, K.; Wu, G.; et al. Diversity of STs, plasmids and ESBL genes among Escherichia coli from humans, animals and food in
Germany, the Netherlands and the UK. J. Antimicrob. Chemother. 2016, 71, 1178–1182. [CrossRef]
51. Manges, A.R.; Johnson, J.R. Reservoirs of extraintestinal pathogenic Escherichia coli. Microbiol. Spectr. 2015, 3. [CrossRef]
52. Manges, A.R.; Geum, H.M.; Guo, A.; Edens, T.J.; Fibke, C.D.; Pitout, J.D.D. Global extraintestinal pathogenic Escherichia coli
(ExPEC) lineages. Clin. Microbiol. Rev. 2019, 32. [CrossRef]
53. Espadale, E.; Pinchbeck, G.; Williams, N.J.; Timofte, D.; McIntyre, K.M.; Schmidt, V.M. Are the hands of veterinary staff a
reservoir for antimicrobial-resistant bacteria? A randomized study to evaluate two hand hygiene rubs in a veterinary hospital.
Microb. Drug Resist. 2018, 24, 1607–1616. [CrossRef]
54. Kampf, G.; Löffler, H.; Gastmeier, P. Hand hygiene for the prevention of nosocomial infections. Dtsch. Aerzteblatt Online 2009, 106,
649–655. [CrossRef]
55. Aunger, R.; Greenland, K.; Ploubidis, G.; Schmidt, W.; Oxford, J.; Curtis, V. The Determinants of reported personal and household
hygiene behaviour: A multi-country study. PLoS ONE 2016, 11, e0159551. [CrossRef]
56. Stull, J.W.; Bjorvik, E.; Bub, J.; Dvorak, G.; Petersen, C.; Troyer, H.L. 2018 AAHA infection control, prevention, and biosecurity
guidelines. J. Am. Anim. Hosp. Assoc. 2018, 54, 297–326. [CrossRef]
Antibiotics 2021, 10, 171 14 of 14
57. Walther, B.; Hermes, J.; Cuny, C.; Wieler, L.H.; Vincze, S.; Elnaga, Y.A.; Stamm, I.; Kopp, P.A.; Kohn, B.; Witte, W.; et al. Sharing
more than friendship—Nasal colonization with coagulase-positive staphylococci (CPS) and co-habitation aspects of dogs and
their owners. PLoS ONE 2012, 7, e35197. [CrossRef] [PubMed]
58. Geser, N.; Stephan, R.; Korczak, B.M.; Beutin, L.; Hächler, H. Molecular identification of extended-spectrum-β-lactamase genes
from enterobacteriaceae isolated from healthy human carriers in Switzerland. Antimicrob. Agents Chemother. 2011, 56, 1609–1612.
[CrossRef] [PubMed]
59. Woodford, N.; Fagan, E.J.; Ellington, M.J. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum
β-lactamases. J. Antimicrob. Chemother. 2005, 57, 154–155. [CrossRef] [PubMed]
60. Zurfluh, K.; Nüesch-Inderbinen, M.; Morach, M.; Berner, A.Z.; Hächler, H.; Stephan, R. Extended-spectrum-β-lactamase-
producing enterobacteriaceae isolated from vegetables imported from the Dominican Republic, India, Thailand, and Vietnam.
Appl. Environ. Microbiol. 2015, 81, 3115–3120. [CrossRef] [PubMed]
61. The Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 28th ed.; CLSI:
Wayne, PA, USA, 2018.
62. Wirth, T.; Falush, D.; Lan, R.; Colles, F.; Mensa, P.; Wieler, L.H.; Karch, H.; Reeves, P.R.; Maiden, M.C.J.; Ochman, H.; et al. Sex and
virulence in Escherichia coli: An evolutionary perspective. Mol. Microbiol. 2006, 60, 1136–1151. [CrossRef] [PubMed]
63. Diancourt, L.; Passet, V.; Verhoef, J.; Grimont, P.A.D.; Brisse, S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial
isolates. J. Clin. Microbiol. 2005, 43, 4178–4182. [CrossRef] [PubMed]
64. Stevens, M.J.A.; Cernela, N.; Müller, A.; Stephan, R.; Bloemberg, G. Draft genome sequence of salmonella bongori N19-781, a
clinical strain from a patient with diarrhea. Microbiol. Resour. Announc. 2019, 8, e00691-19. [CrossRef] [PubMed]
